
News|Articles|November 1, 2024
Culture Biosciences’ Mammalian Bioreactors: A Characterization Data Report
Author(s)Culture Biosciences
Culture Biosciences provides cloud-enabled 250mL bioreactors designed for various applications, including mammalian cell cultivation. Accurate transfer of process setpoints is critical to ensuring the success of moving client processes from other systems to Culture’s bioreactors. This whitepaper presents a detailed characterization study of Culture’s mammalian cell bioreactors, highlighting the precision and consistency achieved during process transfer.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Developing Next-Gen Cell Lines Using Targeted Integration
2
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
3
Norgine Secures Hepatitis Delta Therapy Rights Across Key Region
4
FAQ: What You Need to Know about the Current Antibody Pipeline
5